Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery.
about
Investigation of serum protein profiles in scrapie infected sheep by means of SELDI-TOF-MS and multivariate data analysis.A mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups.Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometryOvarian cancer classification based on dimensionality reduction for SELDI-TOF data.Proteomic technologies for the discovery of type 1 diabetes biomarkersAdvances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologiesPredicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.Biomarkers for type 1 diabetes.Novel biomarkers in type 1 diabetes.Proteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes.The progress and potential of proteomic biomarkers for type 1 diabetes in children.Gender dimorphism in regulation of plasma proteins in streptozotocin-induced diabetic rats.
P2860
Q30694957-0A59FD4D-1ACC-4D04-A79C-CA5A004CA8D4Q33279912-DEB1C928-89EC-42C0-8882-0EE0EE0587D1Q33322569-E37D8985-36CE-4999-AC24-AC7FBF6232FFQ33534880-6B6FB726-6A79-44AF-B33F-281BB6C159DFQ33642475-45AB6485-C98E-45C8-82D3-9528045D0652Q34157932-5DF855E2-2E6D-47EF-BA6B-D904DF1D1C2FQ35070288-8090E12C-FFD8-45CE-8E31-57BB4E11F909Q37000150-04872CD8-5262-40AA-8111-809774AC16F0Q37088197-2A2B2AE1-A6A8-4EBB-A8E0-35D855EE5457Q38045278-BC03E93D-5B2F-4F66-862C-FB1E209F2939Q38425675-B470E931-5DF8-4A2C-B05F-5787AD81BD8AQ48720838-73394BD5-E640-41D1-B4E6-A40C592DF161Q50899001-20976BBC-0C5F-45A6-863C-F299D3D74457
P2860
Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@ast
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@en
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@nl
type
label
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@ast
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@en
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@nl
prefLabel
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@ast
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@en
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@nl
P2093
P2860
P356
P1433
P1476
Assessing the utility of SELDI ...... proteomic biomarker discovery.
@en
P2093
Diane Hopkins
Jin-Xiong She
Robert Podolsky
Yi-Hua Huang
P2860
P304
P356
10.1002/PMIC.200600420
P577
2006-12-01T00:00:00Z